New research uncovers a dual-targeting strategy to starve prostate tumors of critical nutrients, offering a potential path to more effective treatments for the disease.

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a portfolio prioritization, focusing resources on ...

Chemotherapy treatment can adversely affect people in your household, a woman undergoing it has warned on TikTok ...

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the ...

Advice for dealing with loss and holiday grief, a physician-scientist explains using “biological age” as a tool to predict early colorectal cancer risk, blood cancer experts share research insights ...

Heightening trial efficiency helps those with breast cancer and other forms of diseases. 10 Breast cancer affects people worldwide ... If you have any questions or concerns about the products and ...

New machine learning-based screening method is 98 pc effective in detecting the earliest sign of breast cancer, according to ...

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

The Business and Innovation Office works with ICR researchers to protect, market and licence technologies created in the ICR laboratories. The wide range of oncology research undertaken at the ICR ...

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to ...